GMC2028E-ALLEVYN-LONDON-IMAGE-1a-With-Nurse

ALLEVYN COMPLETE CARE Foam Dressing

A new dressing designed to offer complete care and superior wound management.

ALLEVYN-COMPLETE-CARE-FRONT- All family (RGB - 100pp).psd

Introducing ALLEVYN COMPLETE CARE

When every day is different and every wound presents new challenges, supporting consistent care delivery has never been more important.

Backed by over 35 years of wound care experience, we combine our deep expertise with advanced innovation. We know wounds – and you know your patients.

Minimising leakage1,2, prolonging wear time 3,4 and helping reduce the impact of shear forces5-7 are central to getting patients back to what they love.

Because when it comes to preventing or healing wounds, your choice of dressing really matters.

For a complete solution that targets both pressure injury prevention and wound management, choose confidence with ALLEVYN COMPLETE CARE Dressing.

Together, we’re shaping what’s possible in wound care.

It’s possible to minimise disruption

Uninterrupted healing supports wound progress and recovery – which means more predictable care patterns, saved resources and less anxiety for worried patients.8

Every ALLEVYN COMPLETE CARE Foam Dressing contains advanced ExuLOCK Technology to help lock in significantly more exudate*9 and bacteria than leading competitors†10,11, and an ExuMASK Change Indicator layer to minimise strikethrough and enable extended wear times.2-4,12 By avoiding clinically unnecessary changes, the dressing can stay in place for longer – and patients can focus on getting back to what they love.

It's possible to help restore quality of life

Restore patient confidence with a comfortable‡13 foam dressing that helps maintain an optimal wound healing environment.1,14-17

Proven higher absorbency,*9 better fluid retention§9 and an ALLEVYN 5-layer dressing that stays in place for longer|| gives patients the confidence to go about their daily lives.3 And with ExuMASK and ExuLOCK Technologies keeping leakage well under control,1,2,15,17 it helps minimise pooling and maceration1,12,15, so patients benefit from more time to enjoy life rather than worrying about the next dressing change.

Shutterstock_2585957843_RT-V2

It’s possible to optimise resources

When you work with a partner that does much of the hard work for you, it’s easy to reduce wastage and make savings along the way.

ALLEVYN COMPLETE CARE Dressing supports a wear time of up to 7 days. ALLEVYN 5-layer dressings have been shown to stay in place for up to 30% longer than other foam dressings.||3 That means fewer dressing changes, less wastage |2,3,18 and time back in your busy nursing schedule. A visual change indicator means patients also benefit from the confidence and flexibility to take some control of their own wound healing journey through shared care practices.4,19

ACC-Getty-Image-RT-CUTOUT-RGB

From patient insight to design innovation

Join our R&D team as we explore the technology and design thinking that sparked ALLEVYN COMPLETE CARE.

How it works: 5-layer breakdown

ALLEVYN COMPLETE CARE Dressing’s 5-layer technology does everything you’d expect from a superior foam dressing – and more.

GMC1615-ALLEVYN-COMPLETE-CARE-AVENGER-SQUARE-FLICK-WITH-LABELS

Don't miss out – get your sample today!

Minimise leakage, defend against the factors that lead to pressure injury, and get patients back to what they love with ALLEVYN COMPLETE CARE Dressing.

References

* p<0.001; as demonstrated in vitro 

† Tested in-vitro (bacteria within simulated wound exudate), n=9, 3 batches. Superiority met (p <0.01) dependent on challenge volume tested. 

‡ As demonstrated in a volunteer trial. 120 volunteers wore the dressing on intact skin for up to 7 days on their thighs or shins. 

§ p<0.001; as demonstrated in vitro; compared to leading competitors 

|| vs. other foam dressings (includes: other foam dressings, gelling fibers, protease-modulating dressing, contact layers, etc.) 

¶ Tested in-vitro (bacteria within simulated wound exudate), n=9, 3 batches. Superiority met (p <0.01) dependent on challenge volume tested. 

**As demonstrated in vitro 

  1. Smith+Nephew 2025. Free swell Absorbency and Retention after Compression Testing of ALLEVYN COMPLETE CARE Dressing. Internal report: CSD.AWM.25.008.
  2. Tiscar-González V, Menor-Rodríguez MJ, Rabadán-Sainz C, et al. Clinical and Economic Impact of Wound Care Using a Polyurethane Foam Multilayer Dressing. Adv Skin Wound Care. 2021;34(1):23-30.
  3. Atkinson L, Allen D, Costa B. Poster presented at: European Wound Management Association (EWMA); May 1–3, 2024; London, UK. (NB: EM meta-analysis)
  4. Costa B, Allen D. Poster presented at: European Wound Management Association (EWMA); May 3–5, 2023; Milan, Italy.
  5. Smith+Nephew 2024. Comparison of Frictional Energy Absorber Effectiveness (FEAE) in two five-layer hydrocellular polyurethane foam dressings (HPFD) containing superabsorber and masking layers. Internal report: CSD.AWM.24.057 V2.
  6. Smith+Nephew 2024. Finite Element Modelling (FEM) of ALLEVYN COMPLETE CARE Dressing as a prophylactic dressing used to protect the posterior heel. Internal report: CSD.AWM.24.058 V2.
  7. Atkinson L, Costa B. Poster presented at: European Wound Management Association (EWMA);Pressure Injury Prevention with A Unique Multi-Layer Foam Dressing: A Systematic Review and Meta-Analysis of Randomized Controlled trials. May 1–3, 2024; London, UK. (NB: PIP meta-analysis)
  8. Moore Z, Loney A, Probst S, Sandoz H, Ryan H, Milne C, et al. 3.5 billion hours of nursing time released by 2030: Potential efficiency gains from shared care and long-wear advance foam dressings. Wounds International. 2022;13(2) 10-6.
  9. Smith+Nephew 2025. Internal report: CSD.AWM.25.042 V2.
  10. Smith+Nephew 2025. Bacterial retention testing of ALLEVYN◊ COMPLETE CARE Dressing and Mepilex Border Flex. Internal report: CSD.AWM.25.021 V2.
  11. Smith+Nephew 2025. Bacterial retention testing of ALLEVYN◊ COMPLETE CARE Dressing and CutimedSiltec Sorbact. Internal report: CSD.AWM.25.030 V2.
  12. Smith+Nephew 2025. Wound Models testing over 4 Days – Horizontal, Moderate Flow, Viscous SWF and Wound Models Testing over 7 Days, Horizontal, Moderate Flow of ALLEVYN COMPLETE CARE Dressing. Internal report: CSD.AWM.25.009 V2.
  13. Smith+Nephew 2025. Topline results from ALLEVYN◊ COMPLETE CARE Foam Dressing volunteer trial (HVS2313) on thighs and shins. Internal report: CSD.AWM.25.032.
  14. Smith+Nephew 2025. Wound Models testing over 4 Days – Horizontal, Moderate Flow, Viscous SWF and Wound Models Testing over 7 Days, Horizontal, Moderate Flow of ALLEVYN COMPLETE CARE Dressing. Internal report: CSD.AWM.25.009 V2.
  15. Rossington A, Drysdale, K, and Winter R. Clinical performance and positive impact on patient wellbeing of ALLEVYN Life. Wounds UK. 2013;9(4):91-95.
  16. Smith+Nephew 2025. Fluid Handling Capacity Testing of ALLEVYN COMPLETE CARE Dressing. Internal report: CSD.AWM.25.010.
  17. Smith+Nephew 2025. Moisture Vapour Permeability Testing of ALLEVYN COMPLETE CARE Dressing. Internal report: CSD.AWM.25.011.
  18. Rossington A, Drysdale, K, and Winter R. Clinical performance and positive impact on patient wellbeing of ALLEVYN Life. Wounds UK. 2013;9(4):91-95.
  19. Joy H, Bielby A, Searle R. A collaborative project to enhance efficiency through dressing change practice. J Wound Care. 2015;24(7):312, 314 - 317.
  20. Smith+Nephew 2025. Change Indicator Usability of ALLEVYN COMPLETE CARE. Internal report: CSD.AWM.25.023 V2.
  21. Smith+Nephew 2026. Internal report: CSD.AWM.26.001.
  22. Smith+Nephew 2025. Internal report: CSD.AWM.25.079
  23. Smith+Nephew 2025. Internal report: CSD.AWM.25.021 V2.
  24. Smith+Nephew 2025. Internal report: CSD.AWM.25.030 V2.
  25. Orlova D, Orlov A, Gefen A. The Protective Efficacy of a New Soft Silicone Multi-Layer Dressing in Reducing the Heel Pressure Ulcer Risk. Int Wound J. 2025;22(10):e70764.
  26. Vowden K, Moiemen N, Drysdale K, Mistry C. An open, prospective randomised, multi-centre clinical evaluation of a hydrocellular silicone foam dressing* in the management of exuding chronic and acute wounds. Paper presented at: EWMA; 2011; Brussels.
  27. Hurd T, Gregory L, Jones A, Brown S. A multi-centre in-market evaluation of ALLEVYN Gentle Border. Wounds UK. 2009;5(3):32 - 44.
  28. Smith+Nephew 2025. Internal Report: EA/AWM/GENERAL/001/v2

Title

Text